Global Osteoarthritis Pain Drugs Market Research Report, Competitive, Technology and Forecast Analysis 2026-2033

According to DIResearch＇s in-depth investigation and research, the global Osteoarthritis Pain Drugs market size will reach 12,276 Million USD in 2026 and is projected to reach 18,144 Million USD by 2033, with a CAGR of 5.74% (2026-2033). Notably, the China Osteoarthritis Pain Drugs market has changed rapidly in the past few years. By 2026, China＇s market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

Osteoarthritis pain drugs are medications used to manage the pain and symptoms associated with osteoarthritis, a degenerative joint disease that causes joint pain, stiffness, and reduced mobility. These drugs include nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen, which help reduce inflammation and pain; acetaminophen, which is used for pain relief but has less anti-inflammatory action; and opioid analgesics, like tramadol, prescribed for more severe pain cases. Topical creams and gels containing capsaicin, salicylates, or NSAIDs can also provide localized relief. Additionally, disease-modifying osteoarthritis drugs (DMOADs), such as hyaluronic acid injections, are used to improve joint function and slow disease progression. The choice of osteoarthritis pain medication depends on factors like the severity of pain, individual health considerations, and the potential for side effects.

The major global suppliers of Osteoarthritis Pain Drugs include Pfizer, Bayer, SK Chemicals, GSK, Sanofi, Crystal Genomics, Johnson & Johnson, Sino Biopharmaceutical, Haohai Biological, Freda, Zhejiang Chengyi Pharmaceutical, Bright Future, Jingfeng Pharmaceutical, Chugai Pharmaceutical, Mikasa Seiyaku, Taisho Pharmaceutical, Seikagaku Corporation, GlaxoSmithKline, Eli Lilly, Novartis, Horizon Pharma, Abbott, Mylan, TEVA, Daiichi Sankyo, Almatica Pharma, Tide Pharmaceutical, Astellas Pharma, Iroko Pharmaceuticals, Hengrui Pharmaceutical, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Osteoarthritis Pain Drugs. Focus on analysing the market share, product portfolio, prices, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Osteoarthritis Pain Drugs market. The report data covers historical data from 2021 to 2025, based year in 2026 and forecast data from 2027 to 2033.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Osteoarthritis Pain Drugs market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Osteoarthritis Pain Drugs industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Suppliers of Osteoarthritis Pain Drugs Include:

Pfizer

Bayer

SK Chemicals

GSK

Sanofi

Crystal Genomics

Johnson & Johnson

Sino Biopharmaceutical

Haohai Biological

Freda

Zhejiang Chengyi Pharmaceutical

Bright Future

Jingfeng Pharmaceutical

Chugai Pharmaceutical

Mikasa Seiyaku

Taisho Pharmaceutical

Seikagaku Corporation

GlaxoSmithKline

Eli Lilly

Novartis

Horizon Pharma

Abbott

Mylan

TEVA

Daiichi Sankyo

Almatica Pharma

Tide Pharmaceutical

Astellas Pharma

Iroko Pharmaceuticals

Hengrui Pharmaceutical

Osteoarthritis Pain Drugs Product Segment Include:

Oral Drugs

Injection Drugs

Topical Drugs

Osteoarthritis Pain Drugs Product Application Include:

Medical Care

Personal Care

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global Osteoarthritis Pain Drugs Industry PESTEL Analysis

Chapter 3: Global Osteoarthritis Pain Drugs Industry Porter's Five Forces Analysis

Chapter 4: Global Osteoarthritis Pain Drugs Major Regional Market Size (Revenue) and Forecast Analysis

Chapter 5: Global Osteoarthritis Pain Drugs Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 6: Global Osteoarthritis Pain Drugs Revenue and Forecast Analysis by Product Type

Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 8: Industrial Chain Analysis, Osteoarthritis Pain Drugs Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis

Chapter 9: Research Findings and Conclusion

Chapter 10: Methodology and Data Sources

Table 1： Osteoarthritis Pain Drugs Industry Development Status

Table 2： Osteoarthritis Pain Drugs Industry Development Trends

Table 3： Global Osteoarthritis Pain Drugs Revenue and Growth Rate (CAGR) by Country: 2025 VS 2026 VS 2033 (US$ Million)

Table 4： Global Osteoarthritis Pain Drugs Revenue by Country (2021-2026) & (US$ Million)

Table 5： Global Osteoarthritis Pain Drugs Revenue Market Share by Country (2021-2026)

Table 6： Global Osteoarthritis Pain Drugs Revenue Forecast by Country (2027-2033) & (US$ Million)

Table 7： Global Osteoarthritis Pain Drugs Revenue Market Share Forecast by Country (2027-2033)

Table 8： Global Osteoarthritis Pain Drugs Market Revenue by Key Suppliers (2021-2026) & (US$ Million)

Table 9： Global Osteoarthritis Pain Drugs Revenue Market Share by Key Suppliers (2021-2026)

Table 10： Global Key Suppliers Headquarter and Key Area Sales

Table 11： Market Mergers & Acquisitions, Expansion

Table 12： Global Osteoarthritis Pain Drugs Market Size and Growth Rate (CAGR) Analysis by Type: 2025 VS 2026 VS 2033 (US$ Million)

Table 13： Global Osteoarthritis Pain Drugs Revenue Analysis by Type (2021-2026) & (US$ Million)

Table 14： Global Osteoarthritis Pain Drugs Revenue Forecast Analysis by Type (2027-2033) & (US$ Million)

Table 15： Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 16： Pfizer Osteoarthritis Pain Drugs Product Portfolio

Table 17： Pfizer Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 18： Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 19： Bayer Osteoarthritis Pain Drugs Product Portfolio

Table 20： Bayer Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 21： SK Chemicals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 22： SK Chemicals Osteoarthritis Pain Drugs Product Portfolio

Table 23： SK Chemicals Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 24： GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 25： GSK Osteoarthritis Pain Drugs Product Portfolio

Table 26： GSK Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 27： Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 28： Sanofi Osteoarthritis Pain Drugs Product Portfolio

Table 29： Sanofi Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 30： Crystal Genomics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 31： Crystal Genomics Osteoarthritis Pain Drugs Product Portfolio

Table 32： Crystal Genomics Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 33： Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 34： Johnson & Johnson Osteoarthritis Pain Drugs Product Portfolio

Table 35： Johnson & Johnson Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 36： Sino Biopharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 37： Sino Biopharmaceutical Osteoarthritis Pain Drugs Product Portfolio

Table 38： Sino Biopharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 39： Haohai Biological Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 40： Haohai Biological Osteoarthritis Pain Drugs Product Portfolio

Table 41： Haohai Biological Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 42： Freda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 43： Freda Osteoarthritis Pain Drugs Product Portfolio

Table 44： Freda Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 45： Zhejiang Chengyi Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 46： Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product Portfolio

Table 47： Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 48： Bright Future Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 49： Bright Future Osteoarthritis Pain Drugs Product Portfolio

Table 50： Bright Future Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 51： Jingfeng Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 52： Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Product Portfolio

Table 53： Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 54： Chugai Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 55： Chugai Pharmaceutical Osteoarthritis Pain Drugs Product Portfolio

Table 56： Chugai Pharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 57： Mikasa Seiyaku Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 58： Mikasa Seiyaku Osteoarthritis Pain Drugs Product Portfolio

Table 59： Mikasa Seiyaku Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 60： Taisho Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 61： Taisho Pharmaceutical Osteoarthritis Pain Drugs Product Portfolio

Table 62： Taisho Pharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 63： Seikagaku Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 64： Seikagaku Corporation Osteoarthritis Pain Drugs Product Portfolio

Table 65： Seikagaku Corporation Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 66： GlaxoSmithKline Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 67： GlaxoSmithKline Osteoarthritis Pain Drugs Product Portfolio

Table 68： GlaxoSmithKline Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 69： Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 70： Eli Lilly Osteoarthritis Pain Drugs Product Portfolio

Table 71： Eli Lilly Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 72： Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 73： Novartis Osteoarthritis Pain Drugs Product Portfolio

Table 74： Novartis Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 75： Horizon Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 76： Horizon Pharma Osteoarthritis Pain Drugs Product Portfolio

Table 77： Horizon Pharma Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 78： Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 79： Abbott Osteoarthritis Pain Drugs Product Portfolio

Table 80： Abbott Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 81： Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 82： Mylan Osteoarthritis Pain Drugs Product Portfolio

Table 83： Mylan Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 84： TEVA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 85： TEVA Osteoarthritis Pain Drugs Product Portfolio

Table 86： TEVA Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 87： Daiichi Sankyo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 88： Daiichi Sankyo Osteoarthritis Pain Drugs Product Portfolio

Table 89： Daiichi Sankyo Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 90： Almatica Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 91： Almatica Pharma Osteoarthritis Pain Drugs Product Portfolio

Table 92： Almatica Pharma Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 93： Tide Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 94： Tide Pharmaceutical Osteoarthritis Pain Drugs Product Portfolio

Table 95： Tide Pharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 96： Astellas Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 97： Astellas Pharma Osteoarthritis Pain Drugs Product Portfolio

Table 98： Astellas Pharma Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 99： Iroko Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 100： Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product Portfolio

Table 101： Iroko Pharmaceuticals Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 102： Hengrui Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 103： Hengrui Pharmaceutical Osteoarthritis Pain Drugs Product Portfolio

Table 104： Hengrui Pharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 105： Global Osteoarthritis Pain Drugs Market Size and Growth Rate (CAGR) by Application: 2025 VS 2026 VS 2033 & (US$ Million)

Table 106： Global Osteoarthritis Pain Drugs Revenue Analysis by Application (2021-2026) & (US$ Million)

Table 107： Global Osteoarthritis Pain Drugs Revenue Forecast Analysis by Application (2027-2033) & (US$ Million)

Table 108： Osteoarthritis Pain Drugs Typical Customer List

Table 109： Osteoarthritis Pain Drugs Distributors List

Figure 1： Osteoarthritis Pain Drugs Product Pictures

Figure 2： Oral Drugs Picture Scope

Figure 3： Injection Drugs Picture Scope

Figure 4： Topical Drugs Picture Scope

Figure 5： Medical Care Picture Scope

Figure 6： Personal Care Picture Scope

Figure 7： Global Osteoarthritis Pain Drugs Market Size Analysis：2025 VS 2026 VS 2033 (US$ Million)

Figure 8： Global Osteoarthritis Pain Drugs Market Revenue and Growth Rate Analysis: (2021-2033) & (US$ Million)

Figure 9： Global Osteoarthritis Pain Drugs Revenue Market Share by Country in 2025

Figure 10： United States Osteoarthritis Pain Drugs Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 11： Germany Osteoarthritis Pain Drugs Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 12： Japan Osteoarthritis Pain Drugs Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 13： China Osteoarthritis Pain Drugs Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 14： France Osteoarthritis Pain Drugs Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 15： U.K. Osteoarthritis Pain Drugs Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 16： South Korea Osteoarthritis Pain Drugs Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 17： Canada Osteoarthritis Pain Drugs Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 18： Italy Osteoarthritis Pain Drugs Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 19： Russia Osteoarthritis Pain Drugs Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 20： Mexico Osteoarthritis Pain Drugs Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 21： Brazil Osteoarthritis Pain Drugs Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 22： India Osteoarthritis Pain Drugs Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 23： Vietnam Osteoarthritis Pain Drugs Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 24： Thailand Osteoarthritis Pain Drugs Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 25： South Africa Osteoarthritis Pain Drugs Market Revenue and Growth Rate (2021-2033) & (US$ Million)

Figure 26： Global Osteoarthritis Pain Drugs Revenue Market Share by Key Suppliers in 2025

Figure 27： Global Osteoarthritis Pain Drugs Industry Competition Landscape

Figure 28： Global Osteoarthritis Pain Drugs Market Size by Type (2021-2033) (US$ Million)

Figure 29： Global Osteoarthritis Pain Drugs Market Share by Type: 2026 & 2033

Figure 30： Osteoarthritis Pain Drugs Industry Chain Analysis

Figure 31： Global Osteoarthritis Pain Drugs Revenue Market Share by Application (2021-2033)

Figure 32： Key Interview Objectives

Figure 33： Bottom-Up and Top-Down Research Methods